Valisure, an independent laboratory, entered into a cooperative research and development agreement (CRADA) with the Department of Defense (DoD) to generate objective drug quality data through independent sourcing and testing for metrics that are expected to differentiate the quality of available manufacturers of a given list of drugs. The study is being conducted in response to a mandate in the FY23 National Defense Authorization Act (NDAA), which instructs the DoD to “assess risks to the ...